Raymond James Financial
PRCT icon

Raymond James Financial’s Procept Biorobotics PRCT Stock Holding History

Raymond James Financial’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-15,321
Closed -$346K – 5604
2026
Q2 		$346K Buy
+15,321
New +$384K ﹤0.01% 4743
2025
Q3 		– Sell
-4,985
Closed -$287K – 6290
2025
Q2 		$287K Sell
4,985
-492
-9% -$27.8K ﹤0.01% 4312
2025
Q1 		$319K Sell
5,477
-14,976
-73% -$1.02M ﹤0.01% 4191
2024
Q4 		$1.65M Buy
+20,453
New +$1.75M ﹤0.01% 3106

Other funds holding PRCT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Raymond James Financial's PRCT Position: Q3 2026 in Review

Raymond James Financial sold out of Procept Biorobotics (PRCT) in Q3 2026, closing a stake of 15,321 shares — an estimated $346K sold.

Raymond James Financial first reported a position in PRCT in Q4 2024 and held it in 4 quarters. The position peaked at $1.65M in Q4 2024. 171 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Raymond James Financial reported no remaining Procept Biorobotics position as of Q3 2026 after selling out during the quarter.
  • Raymond James Financial sold 15,321 Procept Biorobotics shares in Q3 2026, an estimated $346K.
  • Raymond James Financial first reported a position in Procept Biorobotics in Q4 2024 and held it in 4 quarters.
  • Raymond James Financial's Procept Biorobotics position peaked at $1.65M in Q4 2024.
  • 171 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.